Joint Formulary & PAD

Continuous Glucose Monitoring - Pregnancy - NON Type 1 Diabetes requiring insulin

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Device
Associated Icons :
Restrictions / Comments :
Important
Dexcom ONE
 

Status 2

Red
Formulations :
  • Device
Associated Icons :
Restrictions / Comments :
Important
Freestyle Libre 3
 

Status 3

Non Formulary
Formulations :
  • Device
Associated Icons :
Restrictions / Comments :
Important

Glucomen Day, GlucoRx Aidex, A8 Touchcare Nano.

Documents :
 

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Continuous Glucose Monitoring
Indication :
Pregnancy - NON Type 1 Diabetes requiring insulin
Group Name :
Keywords :
Pregnant, Gestational Diabetes, Type 2, blood glucose, CGM
Brand Names Include :
A8 Touchcare NANO, nano, Dexcom ONE, Freestyle Libre 3 Glucomen Day, GlucoRx Aidex
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
5
Traffic Light Entries :
3

Other Indications

Below are listed other indications that Continuous Glucose Monitoring is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Pregnancy - NON Type 1 Diabetes requiring insulin.

  • No records returned.

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed that Continuous Glucose Monitoring (real time) is offered to Pregnant women with NON Type I Diabetes requiring insulin with problematic severe hypoglycaemia or unstable blood glucose  in line with NICE guidance 
The following CGM devices have been recommended by APC:

RED traffic light status

  • Freestyle Libre 3    

Initiation and continued supplies will be through the specialist diabetes service.

BLUE traffic light status

  • Dexcom One (rtCGM)

Initiation will be by the diabetes specialist service, who will provide the first 28 days of treatment (and capillary test strips if required), prior to transfer of care to primary care. 

NON-FORMULARY traffic light status

  • A8 Touchcare Nano
  • Glucomen Day
  • GlucoRx Aidex

Use the flow charts below to ensure the most appropriate and cost-effective CGM devices are used to meet patient need